Friday, April 16 Highlights

Integrated Neuroscience Session:
Ischemic Stroke, Interventional, and Endovascular Therapies/Large Vessel Disease

8:00 a.m.–12:00 p.m.

Provides in-depth subspecialty concentration around a topic using a combination of presentations, such as scientific sessions, case studies, short poster talks, discussions, invited lecturers, and poster sessions.

Future of Neuroscience Conference: Frontiers in Neuroimaging: Coming Soon to a Scanner Near You

9:00 a.m.–5:00 p.m.

This interactive day-long program focuses on neuroimaging, and will feature poster sessions, platform presentations, a series of case vignettes, and several invited speakers discussing new developments in the field.

Registration is required to attend this session, in addition to Annual Meeting registration fee.

Clinical Trials Session

12:00 p.m.–1:30 p.m.
MTCC Theatre 102

This midday seminar covers important clinical topics identified from other society meetings that affect patient care. The latest updates within several clinical trials conducted over the course of the last year will be presented with a question and answer period following. The session will cover several scientific topics:

12:00 p.m.–12:15 p.m.
Merit E. Cudkowicz, MD, MSc
"A Phase 2 Study of KNS-760704 (dexpramipexole) in ALS"

12:15 p.m.–12:20 p.m.
Q and A with Dr. Cudkowicz

12:20 p.m.–12:35 p.m.
Albert Lo MD, PhD
"Multi-Site Randomized Trials for activities based interventions in Stroke: VA ROBOTICS"

12:35 p.m.–12:40 p.m.
Q and A with Dr. Lo

12:40 p.m.–12:55 p.m
Brenda L Y Wong, MD
"An International, Randomized, Double-Blind, Placebo-Controlled, Study of the Efficacy and Safety of Ataluren (PTC124) in Nonsense Mutation Duchenne/Becker Muscular Dystrophy"

12:55 p.m.–1:00 p.m.
Q and A with Dr. Wong

1:00 p.m.–1:15 p.m.
Juha O. Rinne MD, PhD, FAAN (presented by co-author Michael Grundman, MD, MPH)
"PET imaging suggests that bapineuzumab, an anti-Aβ monoclonal antibody, reduces amyloid burden in Alzheimer´s disease"

1:15 p.m.–1:20 p.m.
Q and A with Michael Grundman, MD, MPH (Presenting Author)

1:20 p.m.–1:30 p.m.
Open panel with speakers and closing remarks

Integrated Neuroscience Session:
Molecular Markers and Targets in Neuro-oncology

1:00 p.m.–5:00 p.m.

Provides in-depth subspecialty concentration around a topic using a combination of presentations such as scientific sessions, case studies, short poster talks, discussions, invited lecturers, and poster sessions.

Scientific Program Highlights Plenary Session

5:15 p.m.–6:15 p.m.

MTCC, Theater

Moderator: Stefan M. Pulst, MD, FAAN, Chair, Science Committee and Scientific Program Subcommittee

This plenary reviews the most critical new research from more than 2,000 studies presented throughout the 2010 Scientific Program. Education Programs will end at 5:00 p.m. Friday, allowing time for meeting participants to attend this session.